Antibody-drug conjugates (ADCs) are antibody-based therapies that deliver cytotoxic agents to tumor cells. ADCs use monoclonal antibodies to deliver highly potent anti-cancer drugs to tumor cells, thereby allowing targeted delivery of the drug payload. The ability of ADCs to target and kill cancer cells while minimizing toxicity to healthy cells makes them an attractive option for cancer...